These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25010889)
1. Anti-herpesvirus agents: a patent and literature review (2003 to present). Skoreński M; Sieńczyk M Expert Opin Ther Pat; 2014 Aug; 24(8):925-41. PubMed ID: 25010889 [TBL] [Abstract][Full Text] [Related]
2. Herpesviridae and novel inhibitors. Siakallis G; Spandidos DA; Sourvinos G Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535 [TBL] [Abstract][Full Text] [Related]
3. Design and development of antivirals and intervention strategies against human herpesviruses using high-throughput approach. Hornig J; McGregor A Expert Opin Drug Discov; 2014 Aug; 9(8):891-915. PubMed ID: 25003658 [TBL] [Abstract][Full Text] [Related]
4. Natural Products and Their Derivatives against Human Herpesvirus Infection. Ruchawapol C; Yuan M; Wang SM; Fu WW; Xu HX Molecules; 2021 Oct; 26(20):. PubMed ID: 34684870 [TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase and protein kinase in drug-resistant herpesviruses: Heads of a Lernaean Hydra. Topalis D; Gillemot S; Snoeck R; Andrei G Drug Resist Updat; 2018 Mar; 37():1-16. PubMed ID: 29548479 [TBL] [Abstract][Full Text] [Related]
6. [New antivirals for herpesviruses]. Eizuru Y Uirusu; 2005 Jun; 55(1):95-104. PubMed ID: 16308535 [TBL] [Abstract][Full Text] [Related]
7. Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Li R; Hayward SD Trends Microbiol; 2013 Jun; 21(6):286-95. PubMed ID: 23608036 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions. Palù G; Loregian A Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148 [TBL] [Abstract][Full Text] [Related]
9. Testing the susceptibility of human herpesviruses to antivirals. Agut H; Boutolleau D; Deback C; Bonnafous P; Gautheret-Dejean A Future Microbiol; 2009 Nov; 4(9):1111-23. PubMed ID: 19895215 [TBL] [Abstract][Full Text] [Related]
10. The herpesvirus proteases as targets for antiviral chemotherapy. Waxman L; Darke PL Antivir Chem Chemother; 2000 Jan; 11(1):1-22. PubMed ID: 10693650 [TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of antiviral resistance among the herpesvirus group]. Reina J Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408 [No Abstract] [Full Text] [Related]
12. Progress in the development of new therapies for herpesvirus infections. Price NB; Prichard MN Curr Opin Virol; 2011 Dec; 1(6):548-54. PubMed ID: 22162744 [TBL] [Abstract][Full Text] [Related]
13. [Update on new antiviral drug development for human herpesviruses]. Inoue N; Hashimoto K; Fukuchi S Nihon Rinsho; 2012 Apr; 70(4):642-8. PubMed ID: 22568147 [TBL] [Abstract][Full Text] [Related]
14. The implications of resistance to antiviral agents for herpesvirus drug targets and drug therapy. Coen DM Antiviral Res; 1991 May; 15(4):287-300. PubMed ID: 1659311 [TBL] [Abstract][Full Text] [Related]
15. Guanosine analogues as anti-herpesvirus agents. De Clercq E Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1531-41. PubMed ID: 11200257 [TBL] [Abstract][Full Text] [Related]